ELOCTATE
Antihemophilic Factor (Recombinant), Fc Fusion Protein · KIT · Bioverativ Therapeutics Inc.
ELOCTATE is a kit containing antihemophilic factor (recombinant), fc fusion protein, taken intravenous. Manufactured by Bioverativ Therapeutics Inc..
Key Facts
- Brand Name
- ELOCTATE
- Generic Name
- Antihemophilic Factor (Recombinant), Fc Fusion Protein
- NDC Code (Product)
71104-808- Manufacturer
- Bioverativ Therapeutics Inc.
- Dosage Form
- KIT
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125487
- Marketing Start
- 09/06/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is ELOCTATE used for?
ELOCTATE contains Antihemophilic Factor (Recombinant), Fc Fusion Protein. It is a kit taken intravenous. Consult your doctor for specific uses.
Is ELOCTATE a controlled substance?
ELOCTATE is not classified as a controlled substance by the DEA.
What is the generic name for ELOCTATE?
The generic name for ELOCTATE is Antihemophilic Factor (Recombinant), Fc Fusion Protein. There are no other listed brand versions of Antihemophilic Factor (Recombinant), Fc Fusion Protein.
What is the NDC code for ELOCTATE ?
The NDC (National Drug Code) for ELOCTATE is 71104-808, listed by Bioverativ Therapeutics Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)